Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

被引：0
|
作者：
Jiří Pavlů
Myriam Labopin
Riitta Niittyvuopio
Gerard Socié
Ibrahim Yakoub-Agha
Depei Wu
Peter Remenyi
Jakob Passweg
Dietrich W. Beelen
Mahmoud Aljurf
Nicolaus Kröger
Hélène Labussière-Wallet
Zinaida Perić
Sebastian Giebel
Arnon Nagler
Mohamad Mohty
机构：
[1] Imperial College London at Hammersmith Hospital,Centre for Haematology
[2] EBMT Paris Study Office/CEREST-TC/Saint Antoine Hospital,Department of Haematology
[3] HUCH Comprehensive Cancer Center,Stem Cell Transplantation Unit
[4] Saint Louis Hospital,Hematology–BMT
[5] Hopital Claude Huriez,Service des Maladies du Sang
[6] CHRU Lille,Department of Hematology
[7] the First Affiliated Hospital of Soochow University,Department of Bone Marrow Transplantation
[8] Délpesti Centrumkórház–Országos Hematológiai és Infektológiai Intézet,Department of Oncology
[9] University Hospital Basel,Bone Marrow Transplantation Centre
[10] University Hospital of Essen,Service d’hématologie
[11] King Faisal Specialist Hospital and Research Center,Zavod za hematologiju
[12] University Hospital Eppendorf,Division of Hematology and Bone Marrow Transplantation
[13] Centre Hospitalier Lyon Sud,undefined
[14] Klinika za unutarnje bolesti,undefined
[15] Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology,undefined
[16] Chaim Sheba Medical Center,undefined
[17] Tel-Hashomer and Sackler School of Medicine,undefined
来源：
Journal of Hematology & Oncology | / 12卷
关键词：
Measurable residual disease; Allogeneic hematopoietic cell transplantation; Acute lymphoblastic leukemia; Allogeneic; Myeloablative conditioning; Total body irradiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT
    A Spyridonidis
    M Labopin
    C Schmid
    L Volin
    I Yakoub-Agha
    M Stadler
    N Milpied
    G Socie
    P Browne
    S Lenhoff
    M A Sanz
    M Aljurf
    M Mohty
    V Rocha
    Leukemia, 2012, 26 : 1211 - 1217
  • [32] Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
    Savani, Bipin N.
    Labopin, Myriam
    Boumendil, Ariane
    Ehninger, Gerhard
    Ganser, Arnold
    Ayuk, Francis
    Stelljes, Matthias
    Finke, Juergen
    Beelen, Dietrich
    Niederwieser, Dietger
    Stuhler, Gernot
    Glass, Bertram
    Arnold, Renate
    Polge, Emmanuelle
    Gorin, Norbert
    Esteve, Jordi
    Ciceri, Fabio
    Baron, Frederic
    Schmid, Christoph
    Giebel, Sebastian
    Mohty, Mohamad
    Nagler, Arnon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S32 - S32
  • [33] Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT
    Savani, Bipin N.
    Labopin, Myriam
    Bouinendil, Ariane
    Ehninger, Gerhard
    Ganser, Arnold
    Ayuk, Francis
    Stelljes, Matthias
    Finke, Juergen
    Beelen, Dietrich W.
    Niederwieser, Dietger
    Stuhler, Gernot
    Glass, Bertram
    Arnold, Renate
    Polge, Emmanuelle
    Gorin, Norbert Claude
    Esteve, Jordi
    Ciceri, Fabio
    Baron, Frederic
    Schmid, Christoph
    Giebel, Sebastian
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2015, 126 (23)
  • [34] Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia
    Cassaday, Ryan D.
    Garcia, Kelsey-Leigh A.
    Fromm, Jonathan R.
    Percival, Mary-Elizabeth M.
    Turtle, Cameron J.
    Nghiem, Paul T.
    Stevenson, Phillip A.
    Estey, Elihu H.
    BLOOD ADVANCES, 2020, 4 (14) : 3239 - 3245
  • [35] Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT
    Peric, Zinaida
    Labopin, Myriam
    Peczynski, Christophe
    Polge, Emmanuelle
    Cornelissen, Jan
    Carpenter, Ben
    Potter, Mike
    Malladi, Ram
    Byrne, Jenny
    Schouten, Harry
    Fegueux, Nathalie
    Socie, Gerard
    Rovira, Montserrat
    Kuball, Jurgen
    Gilleece, Maria
    Giebel, Sebastian
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2020, 55 (08) : 1560 - 1569
  • [36] Measurable Residual Disease Assessment and Allogeneic Transplantation as Consolidation Therapy in Adult Acute Lymphoblastic Leukemia in Colombia
    Felipe Combariza, Juan
    Arango, Marcos
    Diaz, Laura
    Agudelo, Claudia
    Hernandez, Sonia
    Maria Madera, Ana
    Leon, Guillermo
    Avila, Vladimir
    Bautista, Leonardo
    Valdes, Jaime
    Orduz, Rocio
    Mejia, Fabian
    Moreno, Liliana
    Ramirez, Carlos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E365 - E372
  • [37] Allogeneic Transplantation for Acute Myeloid Leukemia with Monosomy 7 or Deletion 7q: a Study from the Acute Leukemia Working Party (ALWP) of the EBMT
    Poire, Xavier
    Labopin, Myriam
    Polge, Emmanuelle
    Volin, Liisa
    Finke, Jurgen
    Ganser, Arnold
    Blaise, Didier
    Yakoub-Agha, Ibrahim
    Beelen, Dietrich
    Milpied, Noel
    Ledoux, Marie-Pierre
    Socie, Gerard
    Niederwieser, Dietger
    Michallet, Mauricette
    Maertens, Johan
    Cornelissen, Jan
    Craddock, Charles
    Mohty, Mohamad
    Esteve, Jordi
    Nagler, Arnon
    BONE MARROW TRANSPLANTATION, 2018, 53 : 149 - 150
  • [38] PREDICTING MEASURABLE RESIDUAL DISEASE FOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS POSTTRANSPLANTATION
    Wang, Yue-Wen
    Fu, Guo-Mei
    Xu, Lan-Ping
    Wang, Yu
    Cheng, Yi-Fei
    Zhang, Yuan-Yuan
    Zhang, Xiao-Hui
    Liu, Yan-Rong
    Liu, Kai-Yan
    Huang, Xiao-Jun
    Chang, Ying-Jun
    BONE MARROW TRANSPLANTATION, 2024, 59 : 498 - 498
  • [39] Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia and Poor Karnofsky Performance Status. a Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
    Saraceni, Francesco
    Labopin, Myriam
    Niittyvuopio, Riitta
    Socie, Gerard
    Kroger, Nicolaus
    Forcade, Edouard
    Browne, Paul
    Remenyi, Peter
    Cornelissen, Jan
    Robinson, Stephen
    Yakoub-Agha, Ibrahim
    Lamy, Thierry
    Brissot, Eolia
    Savani, Bipin
    Nagler, Arnon
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S108 - S109
  • [40] AUTOLOGOUS STEM CELL TRANSPLANTATION FOR ADULTS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN FIRST COMPLETE REMISSION. A STUDY BY THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT
    Swoboda, Ryszard
    Labopin, Myriam
    Giebel, Sebastian
    Maertens, Johan
    Parovichnikova, Elena
    Broers, Annoek E. C.
    Apperley, Jane
    Helbig, Grzegorz
    Iori, Anna Paola
    Raida, Ludek
    Rambaldi, Alessandro
    Caillot, Denis
    Mayer, Jiri
    Wolf, Dominik
    Ozturk, Mustafa
    Aljurf, Mahmoud
    Rubio, Marie Therese
    Gorin, Norbert Claude
    Lanza, Francesco
    Mohty, Mohamad
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 167 - 168
12345